Cystic Neoplasms of Pancreas

Cystic Neoplasms of Pancreas

Cystic Neoplasms of Pancreas

On this page

Overview & Types - Cystic Conundrums

Pancreatic Cystic Neoplasms (PCNs): Increasingly detected. Key: Differentiate benign vs. malignant/premalignant.

  • SCA (Serous Cystadenoma): Benign. Microcystic pattern ("bunch of grapes"). Central scar. Glycogen-rich cells.
  • MCN (Mucinous Cystic Neoplasm): Almost exclusively women (body/tail). Ovarian-type stroma. Premalignant.
  • IPMN (Intraductal Papillary Mucinous Neoplasm): Main-duct (MD-IPMN) high-risk vs. Branch-duct (BD-IPMN). Premalignant/Malignant.
  • SPN (Solid Pseudopapillary Neoplasm): Young females. Solid & cystic areas. Low-grade malignancy. CT features of SCN and MCN pancreatic cystic neoplasms

⭐ MCNs are found almost exclusively in women (typically perimenopausal) and are characterized by ovarian-type stroma; they do NOT communicate with the pancreatic duct system.

Serous Cystadenoma (SCN) - Benign Bubbles

  • Benign; common in elderly women (>60 yrs).
  • Microcystic ("honeycomb" - most common), oligocystic, solid types.
  • "Sunburst" central scar (often calcified) is pathognomonic.
  • Cyst fluid: ↓CEA, ↓Amylase; glycogen-rich (PAS+).
  • 📌 SCN: Sunburst Central scar, Serous, Safe (benign).
  • Management: Observation if asymptomatic; surgery if symptomatic. Pancreatic Serous Cystadenoma Imaging and Mimics

⭐ Associated with Von Hippel-Lindau (VHL) syndrome in some cases.

Mucinous Cystic Neoplasm (MCN) - Ominous Ovarian Stroma

  • Almost exclusively in women (95%), typically located in pancreatic body/tail.
  • Thick-walled, septated cyst; no communication with pancreatic duct.
  • Pathognomonic: Ovarian-type stroma on histology.
  • 📌 MCN = Mother (female), Malignant potential, Mucinous, Ovarian stroma.
  • Considered premalignant or malignant; can progress to invasive adenocarcinoma.
  • Cyst fluid: ↑ CEA, ↓ amylase.
  • Management: Surgical resection is standard treatment due to malignant risk. Histopathology of Pancreatic Mucinous Cystic Neoplasm

⭐ The presence of ovarian-type stroma is pathognomonic for MCN and confirms the diagnosis.

IPMN - Duct's Dangerous Dilations

  • Mucin-producing neoplasms; cystic dilation of pancreatic ducts.
  • Types: Main-Duct (MD-IPMN), Branch-Duct (BD-IPMN), Mixed-Type (MT-IPMN).
  • High-Risk Stigmata (HRS): Jaundice, enhancing mural nodule ≥5mm, MPD ≥10mm.
  • Worrisome Features (WF): Cyst ≥3cm, MPD 5-9mm, mural nodule <5mm.
  • Management: HRS → Resection. WF → EUS. BD-IPMN (no HRS/WF) → Surveillance.

⭐ Main-duct (MD-IPMN) or mixed-type IPMN with main duct involvement generally warrants resection due to high malignancy risk.

SPN (Hamoudi/Gruber-Frantz) - Solidly Surprising

📌 SPN = Solid & Papillary, Young women, Nuclear β-catenin.

  • AKA: Frantz tumor; Solid pseudopapillary tumor.
  • Typically: Young women (mean age 20-30 yrs).
  • Gross: Well-circumscribed, encapsulated; solid & cystic areas with hemorrhage/necrosis.
  • Micro: Monotonous cells forming solid sheets & pseudopapillae; hyaline globules, foamy histiocytes.
  • Molecular: CTNNB1 (β-catenin) gene mutations.
  • Prognosis: Low malignant potential; >95% survival after complete resection.

⭐ Nuclear β-catenin staining is a characteristic immunohistochemical finding and diagnostic hallmark for SPN of the pancreas, reflecting CTNNB1 gene mutations.

Diagnosis & Workup - Peeking Pancreatic Pockets

  • Imaging (CT/MRI): Defines cyst morphology (size, septa, nodules, MPD link).
  • EUS-FNA: Crucial for fluid analysis.
    • Cytology: Detects malignancy.
    • CEA: > 192 ng/mL (Mucinous) vs. < 5 ng/mL (Serous).
    • Glucose: < 50 mg/dL (Mucinous).
    • Amylase: ↑ in pseudocysts, communicating IPMN.
    • Molecular: KRAS/GNAS (IPMN).
  • Serum CA 19-9: Low specificity for cysts.

EUS-guided FNA of pancreatic cyst

⭐ Cyst fluid CEA > 192 ng/mL strongly suggests a mucinous neoplasm (IPMN or MCN).

High‑Yield Points - ⚡ Biggest Takeaways

  • Serous cystadenomas (SCAs): Benign, microcystic, central scar, "grandmother" lesions.
  • Mucinous cystic neoplasms (MCNs): Women (body/tail), ovarian stroma, premalignant.
  • IPMNs: Involve ducts; main duct type has ↑ malignant risk vs. branch duct.
  • Solid pseudopapillary neoplasms (SPNs): Young females, low malignant potential, β-catenin alterations.
  • Cyst fluid: ↑ CEA in MCN/IPMN; ↑ amylase if duct communication.
  • Sendai/Fukuoka guidelines direct IPMN management.

Practice Questions: Cystic Neoplasms of Pancreas

Test your understanding with these related questions

A patient with jaundice is found to have a pancreatic head mass. What is the best diagnostic test?

1 of 5

Flashcards: Cystic Neoplasms of Pancreas

1/9

What are the indications for conservative mx of pancreatic pseudocyst?_____.Pseudocysts smaller than 4cm in diameterLocated on the tailNo evidence of obstruction or communication with the main pancreatic duct

TAP TO REVEAL ANSWER

What are the indications for conservative mx of pancreatic pseudocyst?_____.Pseudocysts smaller than 4cm in diameterLocated on the tailNo evidence of obstruction or communication with the main pancreatic duct

Asymptomatic pts

browseSpaceflip

Enjoying this lesson?

Get full access to all lessons, practice questions, and more.

Start Your Free Trial